Clinical trial
Randomised Trial on Allogeneic Haematopoietic Stem Cell Transplantation in Patients Under the Age of 60 Years With Acute Myeloid Leukemia of Intermediate Risk in First Complete Remission and a Matched Sibling or Unrelated Donor (ETAL-1)
NCT01246752 is registered in ClinicalTrials.gov with University Hospital Carl Gustav Carus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Trial on Allogeneic Haematopoietic Stem Cell Transplantation in Patients Under the Age of 60 Years With Acute Myeloid Leukemia of Intermediate Risk in First Complete Remission and a Matched Sibling or Unrelated Donor (ETAL-1)
- Lead sponsor
- University Hospital Carl Gustav Carus
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- February 10, 2011
- Completion date
- April 30, 2020
- Enrollment
- 143 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.